UK markets close in 3 hours 3 minutes

  • FTSE 100

    6,696.91
    +58.06 (+0.87%)
     

  • FTSE 250

    20,520.59
    +170.18 (+0.84%)
     

  • AIM

    1,195.32
    -3.24 (-0.27%)
     

  • GBP/EUR

    1.1274
    +0.0016 (+0.14%)
     

  • GBP/USD

    1.3698
    +0.0023 (+0.17%)
     

  • BTC-GBP

    23,116.57
    -550.31 (-2.33%)
     

  • CMC Crypto 200

    636.43
    -10.89 (-1.68%)
     

  • S&P 500

    3,855.36
    +13.89 (+0.36%)
     

  • DOW

    30,960.00
    -36.98 (-0.12%)
     

  • CRUDE OIL

    53.05
    +0.28 (+0.53%)
     

  • GOLD FUTURES

    1,852.20
    -3.00 (-0.16%)
     

  • NIKKEI 225

    28,546.18
    -276.11 (-0.96%)
     

  • HANG SENG

    29,391.26
    -767.75 (-2.55%)
     

  • DAX

    13,911.33
    +267.38 (+1.96%)
     

  • CAC 40

    5,551.28
    +78.92 (+1.44%)
     
COVID-19:

UK economy hangs in balance amid EU vaccine row

The EU said companies will have to provide more information when they export vaccines, which could hit UK supplies

Rights and Issues Investment Trust PLC: Net Asset Value(s)

·2-min read

Rights and Issues Investment Trust PLC (RIII)
04-Jan-2021 / 12:30 GMT/BST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.

 


Rights and Issues Investment Trust Plc

 

 

LEI Number: 2138002AWAM93Z6BP574

The Company announces:

Total Assets (including unaudited revenue reserves at 31/12/2020) of £170.33m

Net Assets (including unaudited revenue reserves at 31/12/2020) of £170.33m

 

 

 

The Net Asset Value (NAV) at 31/12/2020 was:

 

 

Number of shares in issue:

Per Ordinary share - including unaudited current period revenue*

2,258.88p

7,540,321

Per Ordinary share - excluding unaudited current period revenue* 

2,258.29p

 

Ordinary share price (mid-price)

2,105.00p

 

Discount to NAV

6.81%

 

*Current period revenue covers the period 01/01/2020 to 31/12/2020

 

 

 

 

 

Name of company

 

% of portfolio

1

Treatt Plc Ordinary 2p

 

18.12

2

Hill & Smith Holdings Plc Ordinary 25p

 

12.84

3

Scapa Group Plc Ordinary 5p

 

9.46

4

Macfarlane Group Plc Ordinary 25p

 

9.46

5

Spirax-Sarco Engineering Plc Ordinary 26.9231p

 

8.67

6

Vp Plc Ordinary 5p

 

8.59

7

Electrocomponents PLC Ordinary 10p

 

7.20

8

Colefax Group Plc Ordinary 10p

 

6.17

9

Vitec Group Plc Ordinary 20p

 

2.33

10

Renold Plc Ordinary 5p

 

2.29

11

Eleco Plc Ordinary 1p

 

2.24

12

IMI Plc Ordinary 25p

 

2.04

13

Morgan Advanced Materials Plc Ordinary 25p

 

1.98

14

Bellway Plc Ordinary 12.5p

 

1.50

15

Menzies (John) Plc Ordinary 25p

 

1.45

16

Carr's Group Plc Ordinary GBp2.5

 

1.41

17

Castings Plc Ordinary 10p

 

0.92

18

National Grid Plc Ordinary 11.395p

 

0.76

19

Titon Holdings Plc Ordinary 10p

 

0.72

20

GlaxoSmithKline Plc Ordinary 25p

 

0.60

21

Santander UK 10.375% Non Cumulative Preferred

 

0.41

22

Dialight Plc Ordinary 1.89p

 

0.38

23

LPA Group Plc Ordinary 10p

 

0.33

24

Coral Products Plc Ordinary 1p

 

0.11

25

Chamberlin Plc Ordinary 25p

 

0.04

26

Dyson Group Plc Ordinary GBP0.001

 

0.00

27

Costain Group Plc Ordinary 50p

 

0.00

Rights and Issues Investment Trust Plc

 

 

LEI Number: 2138002AWAM93Z6BP574

The Company announces:

Total Assets (including unaudited revenue reserves at 31/12/2020) of £170.33m

Net Assets (including unaudited revenue reserves at 31/12/2020) of £170.33m

 

 

 

The Net Asset Value (NAV) at 31/12/2020 was:

 

 

Number of shares in issue:

Per Ordinary share - including unaudited current period revenue*

2,258.88p

7,540,321

Per Ordinary share - excluding unaudited current period revenue* 

2,258.29p

 

Ordinary share price (mid-price)

2,105.00p

 

Discount to NAV

6.81%

 

*Current period revenue covers the period 01/01/2020 to 31/12/2020

 

 

 

 

 

Name of company

 

% of portfolio

1

Treatt Plc Ordinary 2p

 

18.12

2

Hill & Smith Holdings Plc Ordinary 25p

 

12.84

3

Scapa Group Plc Ordinary 5p

 

9.46

4

Macfarlane Group Plc Ordinary 25p

 

9.46

5

Spirax-Sarco Engineering Plc Ordinary 26.9231p

 

8.67

6

Vp Plc Ordinary 5p

 

8.59

7

Electrocomponents PLC Ordinary 10p

 

7.20

8

Colefax Group Plc Ordinary 10p

 

6.17

9

Vitec Group Plc Ordinary 20p

 

2.33

10

Renold Plc Ordinary 5p

 

2.29

11

Eleco Plc Ordinary 1p

 

2.24

12

IMI Plc Ordinary 25p

 

2.04

13

Morgan Advanced Materials Plc Ordinary 25p

 

1.98

14

Bellway Plc Ordinary 12.5p

 

1.50

15

Menzies (John) Plc Ordinary 25p

 

1.45

16

Carr's Group Plc Ordinary GBp2.5

 

1.41

17

Castings Plc Ordinary 10p

 

0.92

18

National Grid Plc Ordinary 11.395p

 

0.76

19

Titon Holdings Plc Ordinary 10p

 

0.72

20

GlaxoSmithKline Plc Ordinary 25p

 

0.60

21

Santander UK 10.375% Non Cumulative Preferred

 

0.41

22

Dialight Plc Ordinary 1.89p

 

0.38

23

LPA Group Plc Ordinary 10p

 

0.33

24

Coral Products Plc Ordinary 1p

 

0.11

25

Chamberlin Plc Ordinary 25p

 

0.04

26

Dyson Group Plc Ordinary GBP0.001

 

0.00

27

Costain Group Plc Ordinary 50p

 

0.00

ISIN:

GB0007392078

Category Code:

NAV

TIDM:

RIII

LEI Code:

2138002AWAM93Z6BP574

OAM Categories:

3.1. Additional regulated information required to be disclosed under the laws of a Member State

Sequence No.:

90767

EQS News ID:

1158249


 

End of Announcement

EQS News Service

show this
show this

Latest stories

  • Man United vs Sheffield United: Prediction, TV channel, live stream, team news, latest odds, h2h results

    Manchester United will be expecting to continue their Premier League title challenge as they host Sheffield United on Wednesday. Ole Gunnar Solskjaer’s side are unbeaten in the Premier League since losing to Arsenal way back at the start of November and victory over rivals Liverpool in the FA Cup at the weekend will only have added to their momentum. United face a potentially tricky trip to the Gunners next up at the weekend so will be desperate to keep their run going by taking three points against the Premier League’s bottom side.

  • Rare grass worth £40-a-bunch being removed by 'droves' of people from beach in the North East

    Pampas grass, which is increasingly popular among interior deisgners, grows wild near Littlehaven Beach in South Shields.

  • Covid Infection Rates Are Falling. So Why Is There ‘A Very Long Way’ To Go?

    Alarm bells still ringing despite cases dropping significantly and hopes the daily death toll might soon pass its peak.

  • iSun Energy Announces $2.2 Million Contract for Solar EV Charging and Energy Infrastructure with Meriden Housing Authority

    iSun, Inc. (NASDAQ: ISUN) ("iSun") is a leading solar industry innovator and commercial solar contractor providing energy services, smart city innovations and clean mobility infrastructure with solar electric vehicle (EV) charging, ground-mount and rooftop solar energy systems and electrical and data services. Today, iSun announces that it has been selected by competitive bid to provide its innovative solar EV carport, rooftop and ground-mount technologies to the Meriden Housing Authority for two locations in Bristol, CT.

  • Graham Potter keen to improve home form but happy to pick up points anywhere

    Brighton are yet to toast a Premier League victory at the Amex Stadium this season.

  • Worldwide Higher Education M-learning Market to 2025 - Key Drivers, Challenges and Trends - ResearchAndMarkets.com

    The "Global Higher Education M-learning Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.

  • How the Parler takedown has dealt another blow to the British far right

    At one point, extremists such as Tommy Robinson and Britain First had a significant presence on social media. But the latest shutdown shows how deplatforming has fragmented their audiences and left them struggling to gain followers, writes Lizzie Dearden

  • It's A Sin Creator Russell T Davies Reveals Why The Series Was Nearly Never Made

    The writer came across several roadblocks when he first started pitching the drama to TV execs in 2015.

  • NHS boss says new COVID treatments in second half of 2021 offer hope of 'much more normal future'

    NHS boss Sir Simon Stevens said coronavirus should become 'much more treatable' in hospitals in the second half of the year.

  • Make Britain Great Again: How Ukip tried to ride the Trump wave – and it ended in disaster

    As Ukip welcomes Katie Hopkins as a member, Lizzie Dearden looks at the party’s journey into the far right

  • Is Stitch Fix's Valuation Getting Ahead of Itself?

    Stitch Fix (NASDAQ: SFIX) is no exception. Shares in the online styling service are nearly 700% during that time frame, making it one of the best-performing stocks of the past year. Have investors missed the boat with Stitch Fix?

  • Kobe Bryant’s Promising, Unfulfilled Entertainment Industry Legacy

    When Kobe Bryant died one year ago today, the news arrived as a shock, particularly in the Los Angeles area where Bryant was widely beloved. Bryant, who died in a helicopter crash alongside eight other people, among them his 13-year-old daughter Gianna, was 41. Just four years earlier, he played his last game in an […]

  • AI Genomics Company, NRGene, Completes Initial Public Offering on Tel-Aviv Stock Exchange and Raises NIS 100 Million (~US$30 Million)

    NRGene (Tel Aviv Stock Exchange: NRGN), an AI based genomic company operating in the agricultural and livestock industry, announced today that it has successfully completed its initial public offering on the Tel Aviv Stock Exchange (TASE). NRGene raised ~NIS 100 Million (~US$30 Million), with a post-money valuation of circa NIS 370 Million (~NIS 420 Million on a fully diluted basis). Leading institutional entities in the Israeli market have invested in the current IPO.

  • DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Fortress Biotech, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

    DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Fortress Biotech, Inc.

  • Canadian politicians agree to designate Proud Boys as terrorist entity

    Motion passed with unanimous consent in House of Commons on Monday

  • Dani Dyer shares sweet picture of her baby boy

    She became a mum on January 23.

  • Q&A: How will Joe Root’s England fare against Virat Kohli’s India?

    Having beaten Sri Lanka, the tourists face a step up in quality with a four-Test trip to India.

  • Insights on the Cryogenic Vials Global Market to 2026 - Opportunity Analysis for New Entrants

    Dublin, Jan. 26, 2021 (GLOBE NEWSWIRE) -- The "Global Cryogenic Vials Market Analysis 2020" report has been added to ResearchAndMarkets.com's offering. The global cryogenic vials market is expected to reach $218.08 million by 2026 growing at a CAGR of 5.9% during 2019 to 2026. Cryogenic vials are utilized for the long-term storage of samples and are considered to be the best and most leak-resistant for this purpose. It is highly useful for the storage of various specimens and also different biological materials at ultra-low temperatures. The superfast thread design of the vial helps in the removal as well as tightening. They are mostly packaged in exclusive safety-lock bags that are tamper-proof.The factors such as increased growth and expansion of pharmaceutical industries across the globe, growing prominence of chronic diseases like cancer, diabetes, and communicable diseases, increasing command in drug research, and increasing pace of industrialization are driving the market growth. However, high cost associated with cryogenic vials is expected to restrain the market growth.Depending on the product type, self-standing cryogenic vials segment is expected to grow at the significant rate during the forecast period, due to their extensive uptake since they don't need extra storage space. Self-standing cryogenic vials are preferred because they eliminate the need of an extra storage space for putting them into cryogenic racks which is mandatorily required for round bottom cryogenic vials.The key vendors mentioned are Incell Technologies, Azer Scientific, Inc., E&K Scientific Products, Inc., DWK Life Sciences GmbH, Sigma-Aldrich Corporation, Thermo Fisher Scientific Inc., Corning Incorporated, VWR International LLC, BioCision, LLC, Sumitomo Bakelite Co., Ltd, Starlab International GmbH, Ziath Ltd, Argos Technologies, Inc, BIOLOGIX GROUP LTD, Evergreen Scientific, and CELLTREAT Scientific Products.Capacity Types Covered: 5 ml and Above2 ml-5 ml1 ml-2 ml0.5 ml-1 ml Product Types Covered: Round BottomSelf-Standing Material Types Covered: Polyethylene (PE)Polypropylene (PP)Polyhydroxyalkanoate (PHA)Polylactic Acid (PLA)Low-density polyethylene (LDPE)High-density polyethylene (HDPE) Closure Types Covered: Internal ThreadExternal Thread End Users Covered: Drug ManufacturingHealthcare InstitutionsClinical Research OrganizationsHospital & Diagnostic CenterPharma / Biotechnological Manufacturer Sterilities Covered: Non-SterileGamma IrradiatedSterile Regions Covered: North AmericaEuropeAsia PacificSouth AmericaMiddle East & Africa Key Questions Answered in this Report: How this market evolved since the year 2018Market size estimations, forecasts and CAGR for all the segments presented in the scopeKey Market Developments and financials of the key playersOpportunity Analysis for the new entrantsSWOT Analysis of the key playersFastest growing markets analysed during the forecast period Key Topics Covered: 1 Market Synopsis 2 Research Outline 2.1 Research Snapshot 2.2 Research Methodology 2.3 Research Sources 2.3.1 Primary Research Sources 2.3.2 Secondary Research Sources 3 Market Dynamics 3.1 Drivers 3.2 Restraints 4 Market Environment 4.1 Bargaining power of suppliers 4.2 Bargaining power of buyers 4.3 Threat of substitutes 4.4 Threat of new entrants 4.5 Competitive rivalry 5 Global Cryogenic Vials Market, by Capacity Type 5.1 Introduction 5.2 5ml and Above 5.3 2ml-5ml 5.4 1ml-2ml 5.5 0.5ml-1ml 6 Global Cryogenic Vials Market, by Product Type 6.1 Introduction 6.2 Round Bottom 6.3 Self-Standing 7 Global Cryogenic Vials Market, by Material Type 7.1 Introduction 7.2 Polyethylene (PE) 7.3 Polypropylene (PP) 7.4 Polyhydroxyalkanoate (PHA) 7.5 Polylactic Acid (PLA) 7.6 Low-density polyethylene (LDPE) 7.7 High-density polyethylene (HDPE) 8 Global Cryogenic Vials Market, by Closure Type 8.1 Introduction 8.2 Internal Thread 8.3 External Thread 9 Global Cryogenic Vials Market, by End User 9.1 Introduction 9.2 Drug Manufacturing 9.3 Healthcare Institutions 9.4 Clinical Research Organizations 9.5 Hospital & Diagnostic Center 9.6 Pharma / Biotechnological Manufacturer 10 Global Cryogenic Vials Market, by Sterility 10.1 Introduction 10.2 Non-Sterile 10.3 Gamma Irradiated 10.4 Sterile 11 Global Cryogenic Vials Market, by Geography 11.1 Introduction 11.2 North America 11.3 Europe 11.4 Asia Pacific 11.5 South America 11.6 Middle East & Africa 12 Strategic Benchmarking 13 Vendors Landscape 13.1 Incell Technologies 13.2 Azer Scientific, Inc. 13.3 E&K Scientific Products, Inc. 13.4 DWK Life Sciences GmbH 13.5 Sigma-Aldrich Corporation 13.6 Thermo Fisher Scientific Inc. 13.7 Corning Incorporated 13.8 VWR International LLC 13.9 BioCision, LLC 13.10 Sumitomo Bakelite Co., Ltd 13.11 Starlab International GmbH 13.12 Ziath Ltd 13.13 Argos Technologies, Inc 13.14 BIOLOGIX GROUP LTD 13.15 Evergreen Scientific 13.16 CELLTREAT Scientific Products For more information about this report visit https://www.researchandmarkets.com/r/80nrt8 CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

  • How Can I Minimize My Chances of an Audit?

    Worried about an IRS audit? Do these things, and you're less likely to have your return flagged for one.

  • Former Bachelorette Rachel Lindsay Reveals the “Key to Survival” on 'The Bachelor '

    It's not what you'd expect.